NEW YORK, NY / ACCESSWIRE / December 10, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

Infosys Limited (NYSE:INFY)

INFY Lawsuit on behalf of: investors who purchased July 7, 2018 – October 20, 2019
Lead Plaintiff Deadline : December 23, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/infosys-limited-loss-form?prid=4807&wire=1

According to the filed complaint, during the class period, Infosys Limited made materially false and/or misleading statements and/or failed to disclose that: (1) the Company improperly recognized revenues to inflate short-term profits; (2) Chief Executive Officer Salil Parekh bypassed reviews and approvals for large deals to avoid accounting scrutiny; (3) management pressured the Company's finance team to hide information from auditors and the Company's Board of Directors; and (4) as a result of the aforementioned misconduct, Defendants' statements about Infosys's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

Pareteum Corporation (NASDAQ:TEUM)

TEUM Lawsuit on behalf of: investors who purchased December 14, 2017 – October 21, 2019
Lead Plaintiff Deadline : December 23, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/pareteum-corporation-loss-form?prid=4807&wire=1

According to the filed complaint, during the class period, Pareteum Corporation made materially false and/or misleading statements and/or failed to disclose that: (a) it was not true that the Company's purported success was the result of hyper-demand for Pareteum's unique products or exceptional service, or the Company's competent management; but, in fact, Defendants had propped up the Company's results by manipulating Pareteum's accounting for revenues, income, and the important Backlog metric; (b) Defendants had materially overstated the Company's profitability by failing to properly account for the Company's results of operations and by artificially inflating the Company's financial results; (c) it was not true that Pareteum contained even the most minimally adequate systems of internal operational or financial controls necessary to assure that Pareteum's reported financial statements were true, accurate, and/or reliable; (d) as a result, it also was not true that the Company's financial statements and reports were prepared in accordance with GAAP and SEC rules; and (e) as a result of the aforementioned adverse conditions, Defendants lacked any reasonable basis to claim that Pareteum was operating according to plan, or that Pareteum could achieve the guidance sponsored and/or endorsed by Defendants.

Quad/Graphics, Inc. (NYSE:QUAD)

QUAD Lawsuit on behalf of: investors who purchased February 21, 2018 – October 29, 2019
Lead Plaintiff Deadline : January 6, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/quad-graphics-inc-loss-form?prid=4807&wire=1

According to the filed complaint, during the class period, Quad/Graphics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's book business in United States was underperforming; (2) as a result, the Company was likely to divest its book business; (3) the Company was unreasonably vulnerable to decreases in market prices; (4) to remain financially flexible while market prices decreased, the Company was likely to cut its quarterly dividend and expand its cost reduction programs; and (5) as a result of the foregoing, positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 569747

NEW YORK, NY / ACCESSWIRE / December 10, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

Sealed Air Corporation (NYSE:SEE)

SEE Lawsuit on behalf of: investors who purchased November 5, 2014 – August 6, 2018
Lead Plaintiff Deadline : December 31, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/sealed-air-corporation-loss-form?prid=4806&wire=1

According to the filed complaint, during the class period, Sealed Air Corporation made materially false and/or misleading statements and/or failed to disclose that: (a) Sealed Air had hired its auditor, E&Y, pursuant to a conflicted and improper process and in order to help facilitate defendants' efforts to engage in accounting fraud; (b) Sealed Air's deduction of $1.49 billion in connection with the Settlement was indefensible and done for the improper purpose of artificially inflating the Company's financial results; (c) Sealed Air had artificially inflated its earnings, cash flows, and operating income during the Class Period; (d) as a result of the above, Sealed Air's Class Period financial statements were materially false and misleading and not prepared in conformance with GAAP; and (e) as a result of the above, Sealed Air's statements regarding its financial results, business, and prospects were materially misleading.

Under Armour, Inc. (NYSE:UA)

UA Lawsuit on behalf of: investors who purchased August 3, 2016 – November 1, 2019
Lead Plaintiff Deadline : January 6, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/under-armour-inc-loss-form?prid=4806&wire=1

According to the filed complaint, during the class period, Under Armour, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Under Armour shifted sales from quarter to quarter to appear healthier, including to keep pace with their long-running year-over-year 20% net revenue growth; (2) undisclosed to the investing public, the Company had been under investigation by and cooperating with the U.S. Department of Justice and U.S. Securities and Exchange Commission since at least July 2017; and (3) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Baxter International Inc. (NYSE:BAX)

BAX Lawsuit on behalf of: investors who purchased February 21, 2019 – October 23, 2019
Lead Plaintiff Deadline : January 24, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/baxter-international-inc-loss-form?prid=4806&wire=1

According to the filed complaint, during the class period, Baxter International Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) certain intra-Company transactions, undertaken for the purpose of generating foreign exchange gains and losses, used foreign exchange rate conventions that were not in accordance with GAAP and enabled intra-Company transactions to be undertaken after the related exchange rates were already known; (2) the Company lacked effective internal control over financial reporting; (3) as a result, the Company's financial statements were misstated and would likely require correction or amendment; (4) due to the Company's internal investigation, Baxter would not be able to file its quarterly report for the period ending September 30, 2019, with the SEC on Form 10-Q in a timely manner; and (5) as a result of the foregoing, Defendants' statements about the Company's business and operations lacked a reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 569746

ATLANTA, GA / ACCESSWIRE / December 10, 2019 / Findit, Inc. (OTC PINK:FDIT) owner of Findit.com, a social networking site which provides online marketing services, is featuring Findit members CBD Unlimited for its holiday shopping gift ideas with discounts up to 33%.

With the Holiday Season in full swing and Christmas and Hanukkah just two weeks away, shoppers have already begun looking for unique gift ideas at great prices especially from retailers who offer online shopping. The company we are featuring today is CBD Unlimited who is a member on Findit that utilizes Findit's full service social networking content management online marketing services.

CBD Unlimited is a highly trusted developer of high end hemp derived cannabidiol products from CBD oils to concentrates, pet products, topicals and more.

Right now they are running their CBD Holiday Sale

Online Shoppers 33% off
10ml Premium Orange and Peppermint Oils.
To access this deal use code ‘33%OFFOILS' at checkout.

Findit offers a full suite of online social networking content creation programs to its members that are seeking to increase their overall online web presence, build brand awareness, increase the number of search results and improve their indexing positions in Google, Yahoo and Bing. Findit accomplishes this for CBD Unlimited along with other members on Findit by creating tailored content and sharing that content via social sites in addition to Findit that can include; Facebook, Twitter, Google My Business, LinkedIN and other sites that allow CBD related posts.

Clark St. Amant of Findit stated, "CBD Unlimited has a great collection of high quality CBD products and we have enjoyed working with them to help increase web-traffic and improve overall indexing in search engines which in turn has lead more people to these two companies who otherwise might not have known who they are."

https://www.youtube.com/watch?v=_hnO1jEBczQ

Findit focuses on reaching the target demographics for each of these members that may or may not be aware of them in an effort to heighten brand awareness of their services and in some cases, their extensive product lines.

About Findit, Inc.

Findit, Inc., owns Findit.com which is a Social Media Content Management Platform that provides an interactive search engine for all content posted in Findit to appear in Findit search. The site is an open platform that provides access to Google, Yahoo, Bing and other search engines access to its content posted to Findit so it can be indexed in these search engines as well. Findit provides Members the ability to post, share and manage their content. Once they have posted in Findit, we ensure the content gets indexed in Findit Search results. Findit provides an option for anyone to submit URLs that they want indexed in Findit search result, along with posting status updates through Findit Right Now. Status Updates posted in Findit can be crawled by outside search engines which can result in additional organic indexing. All posts on Findit can be shared to other social and bookmarking sites by members and non-members. Findit provides Real Estate Agents the ability to create their own Findit Site where they can pull in their listing and others through their IDX account. Findit, Inc., is focused on the development of monetized Internet-based web products that can provide an increase in brand awareness of our members. Findit, Inc., trades under the stock symbol FDIT on the OTCPinksheets.

Safe Harbor:

This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements regarding potential sales, the success of the company's business, as well as statements that include the word believe or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Findit, Inc. to differ materially from those implied or expressed.

Contact:

Clark St. Amant
404-443-3224

SOURCE: Findit, Inc.

ReleaseID: 569740

NEW YORK, NY / ACCESSWIRE / December 10, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below. There will be no cost or obligation to you.

Uniti Group Inc. (NASDAQGS:UNIT)

UNIT Lawsuit on behalf of: investors who purchased April 20, 2015 – February 15, 2019
Lead Plaintiff Deadline : December 30, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/uniti-group-inc-loss-form?prid=4803&wire=1

According to the filed complaint, during the class period, Uniti Group Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Uniti's financial results were not sustainable because its customer Windstream had defaulted on its unsecured notes; and (ii) as a result of the foregoing, Defendants' statements about Uniti's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

Domo, Inc. (NASDAQ:DOMO)

DOMO Lawsuit on behalf of: investors who purchased shareholders who acquired: (a) Domo common stock pursuant and/or traceable to the Company's initial public offering commenced on or around June 29, 2018; or (b) Domo securities between June 28, 2018 and September 5, 2019, both dates inclusive.
Lead Plaintiff Deadline : December 16, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/domo-inc-loss-form?prid=4803&wire=1

According to the filed complaint, (i) Domo was experiencing weakness in its enterprise and international businesses; (ii) Domo's billings growth had dramatically slowed; (iii) all of the foregoing was reasonably likely to have a material negative impact on the Company's financial results; and (iv) as a result, the Offering Documents were materially false and/or misleading and failed to state information required to be stated therein and the Company's public statements were materially false and misleading at all relevant times.

Plantronics, Inc. (NYSE:PLT)

PLT Lawsuit on behalf of: investors who purchased July 2, 2018 – November 5, 2019
Lead Plaintiff Deadline : January 13, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/plantronics-inc-loss-form?prid=4803&wire=1

According to the filed complaint, during the class period, Plantronics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company had engaged in channel stuffing to artificially boost sales; (2) the Company's internal control over inventory levels was not effective; (3) the Company had not adequately monitored inventory levels ahead of multiple product launches, where the new models would displace demand for aging products; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 569741

NEW YORK, NY / ACCESSWIRE / December 10, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

The RealReal, Inc. (NASDAQ:REAL)

Investors Affected : all persons and entities who purchased RealReal common stock pursuant and/or traceable to the Company's registration statement issued in connection with the Company's June 27, 2019 initial public offering.

A class action has commenced on behalf of certain shareholders in The RealReal, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's employees received little training on how to spot fake items; (2) the Company's strict quotas on its employees exacerbated product authentication issues; (3) consequently, the potential for counterfeit or mislabeled items to make it through Company's authentication process was higher than disclosed; and (4) as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/the-realreal-inc-loss-submission-form/?id=4805&from=1

Merit Medical Systems, Inc. (NASDAQ:MMSI)

Investors Affected : February 26, 2019 – October 30, 2019

A class action has commenced on behalf of certain shareholders in Merit Medical Systems, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) the integrations of acquired companies Cianna Medical, Inc. and Vascular Insights, LLC, including their products, sales people, and R&D facilities, had caused operational disruptions and reduced sales and were months behind schedule; (b) sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights products which, as late as July 2019, had zero orders during FY19; and (c) in light of the foregoing, the Company's reported financial guidance for FY19 and FY20 was made without a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/merit-medical-systems-inc-loss-submission-form/?id=4805&from=1

Resideo Technologies, Inc. (NYSE:REZI)

Investors Affected : October 29, 2018 – October 22, 2019

A class action has commenced on behalf of certain shareholders in Resideo Technologies, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) the negative operational effects of the Company's spin-off from Honeywell International Inc. were more substantial and persistent than disclosed and had negatively affected Resideo's product sales, supply chain, and gross margins, putting the Company's FY19 financial forecasts at risk; and (b) as a result of the foregoing, the Company's financial guidance lacked a reasonable basis and the Company was not on track to make its FY19 guidance as claimed.

Shareholders may find more information at https://securitiesclasslaw.com/securities/resideo-technologies-inc-loss-submission-form/?id=4805&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 569745

NEW YORK, NY / ACCESSWIRE / December 10, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

ADTRAN, Inc. (NASDAQ:ADTN)

Investors Affected : February 28, 2019 – October 9, 2019

A class action has commenced on behalf of certain shareholders in ADTRAN, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) there were material weaknesses in the Company's internal control over financial reporting; (2) as a result, certain E&O reserves had been improperly reported; (3) as a result, the Company's financial results for certain periods were misstated; (4) there would be a pause in shipments to the Company's Latin American customer; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/adtran-inc-loss-submission-form/?id=4804&from=1

iRobot Corporation (NASDAQ:IRBT)

Investors Affected : November 21, 2016 – October 22, 2019

A class action has commenced on behalf of certain shareholders in iRobot Corporation. The filed complaint alleges that defendants misrepresented the reason for iRobot's acquisitions of Tokyo-based Sales on Demand Corporation and privately-held Robopolis SAS, which was to control the Company's largest distributors so that defendants could inflate sales and revenue figures by stuffing the channel. Defendants further misled investors by repeatedly telling them throughout the Class Period that the Company was seeing continued double-digit revenue growth, and by attributing the growth to increased demand for the Roomba vacuums, when in reality defendants were engaging in channel-stuffing to artificially boost sales. Defendants also misstated that the Company's channel inventory levels had not changed and would not change dramatically from quarter to quarter or year over year, when in fact iRobot was deliberately stuffing the channel in order to claim false revenue growth.

Shareholders may find more information at https://securitiesclasslaw.com/securities/irobot-corporation-loss-submission-form/?id=4804&from=1

Prudential Financial, Inc. (NYSE:PRU)

Investors Affected : February 15, 2019 – August 2, 2019

A class action has commenced on behalf of certain shareholders in Prudential Financial, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) the Company's reserve assumptions failed to account for adversely developing mortality experience in the Individual Life business segment; (b) the Company was not over-reserved, but instead, its reported reserves, particularly for the Individual Life business segment, were insufficient to satisfy its future policy benefits liabilities; and (c) the Company had materially understated its liabilities and overstated net income as a result of flawed assumptions in calculating mortality experience.

Shareholders may find more information at https://securitiesclasslaw.com/securities/prudential-financial-inc-loss-submission-form/?id=4804&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 569742

CHICAGO, IL / ACCESSWIRE / December 10, 2019 / In a groundbreaking decision, a few months ago, the Atlanta Hawks had traded in Evan Turner for Kent Bazemore as "one of their veteran guards". While there was a lot of doubt in the minds of the fans as Turner had traditionally played as a point forward, but the decision "should" reaped gold for the Hawks in their current season. 30-year-old Turner is trying to diversify his game, and he gives credit for such diversification to one man, Dr. Ju Hearn.

Born in 1987 in Chicago, Illinois, Julius Hearn was a basketball player himself. He played for his high school and went to Howard University, Washington DC on scholarship. As a freshman, Ju played point guard, but just as his career was taking off, he got injured tearing right meniscus, which called for surgery. It ended his budding career and dream of playing professional basketball, but he did not give up. He became a JUCO player at Pratt Community College and earned a University of Texas-Pan America scholarship.

After graduating in Kinesiology with an excellent GPA, Dr. Hearn got several degrees in physical therapy, nutrition, business and, oriental medicine. Losing his career to the lack of proper knowledge, he was determined not to let that happen to others. He started his venture – Recharge Athletics, where he uses his extensive knowledge of Western and Eastern medicine to create an optimal physical plan for professional players. But the short-term goal of getting more wins is not the only thing he focuses on. His program also helps his clients to work on long-term improvement of fitness, minimizing injury and pain to prolong their career.

With the help of Dr. Hearn, Evan Turner is hoping to improve and diversify his game, so that he can be ready to help "his team at any position". It also increases his value as a "high IQ basketball player", making him an asset to the team. But above all, he is looking forward to his short-term goal of bringing more wins this season and keeping up with his "basketball conditioning" without building unrealistic stress on the body. "I appreciate Ju's attention to detail and passion that he brings to his training. Everything is well thought out and you can tell he truly enjoys trying to get people better. He's a student of his craft and has a multitude of ways to get you better in the off season," said Evan Turner.

Dr. Hearn's programs reveal how taking care of your body not only helps cope with stress, and fight illnesses; but also prepares for a strong mental and emotional well being.

Media Contact
Name- Karishma Mago,
Email- info@faciliusinc.com
Mobile no- +19293108511
Country- Chicago, Illinois

SOURCE: Faciliusinc

ReleaseID: 569518

Therapy won the award for Best Romance Film from the 2019 Top Shorts Film Festival

NEW YORK, NY / ACCESSWIRE / December 10, 2019 / Founder and CEO of GUION PARTNERS INC. Lindsay Guion is happy to announce that "Therapy" won the title of Best Romance Film at the 2019 Top Shorts Film Festival. Lindsay Guion is the executive producer of the film and also globally represents Barachi, who is the lead actor of the film and performs the music score.

"Therapy" unfolds in a dream state haze, weaving a story of lovers caught up in the spell of passion and desire that soon dissolves into obsession, an ultimatum… and consequences.

"I am extremely honored to be receiving this 2019 Top Shorts Film Festival award for ‘Best Romance Film,'" says Lindsay Guion.

"I am earnestly grateful for the recognition I have received for my work, because I am very sure that every other nominee was as capable if not more, of winning this award."

Lindsay Guion has over 20 years of experience in the music industry. He brings a unique and original understanding of music and technology. His company, GUION PARTNERS INC., works with various high-profile clients from the sports and entertainment sectors.

"I have faced several challenges on my way here, but each one of them has only strengthened me to make me the person I am today; a thorough professional who knows exactly what he wants; someone who sets his eyes on a goal and does not lose sight of it, unless it is achieved. Winning this award would not have been possible without the inspiration I have received from my ex-girlfriend for whom I still have the deepest respect, and from whom I have derived the strength to challenge myself and perform better at each stage." says Lindsay Guion.

"I promise to only get better at my work so that you can see me here for more awards next year (2020). Thank you as I remain humbled!"

For more information, visit https://lindsayguion.com/

About Lindsay Guion

Lindsay Guion is a prominent film and music producer and has been influential to many aspiring artists throughout his 20-year career in the industry. Having worked closely with many Grammy award-winning artists, Lindsay utilizes his creative expertise to recognize new talent. As an entrepreneur, executive, and entertainment professional, he brings a unique perspective to every one of his projects.

CONTACT:

Lindsay Guion
admin@lindsayguion.com

SOURCE: Guion Partners, Inc.

ReleaseID: 569734

He rejoins firm and specializes in agency ownership succession and M&A services

CHICAGO, IL / ACCESSWIRE / December 10, 2019 / Steven Germundson recently rejoined OPTIS Partners as a partner. Based in Minneapolis, Germundson offers insurance agents and brokers deep expertise in agency ownership succession planning and M&A advisory services.

OPTIS Partners is a top-five investment banking and financial consulting firm serving insurance agents and brokers.

Germundson was most recently senior vice president of corporate development at Prime Risk Partners, joining that company shortly after its formation in 2014. During his tenure, Prime Risk grew from scratch to become the 35th largest insurance broker in North America, largely via acquisition.

Before that, he was a co-founder of OPTIS Partners in 2001. His consulting activity focused on internal agency operations, strategic and annual planning, ownership succession planning, and general business consulting.

In 1994 he co-founded a Minneapolis-based insurance agency, NSIA, Inc. where he had overall responsibilities for financial and operations management and the firm's acquisition activity. He began his career with Hales & Associates in 1987 where he was a consultant working with independent agency owners and managers in both financial and operational consulting engagements.

"Steve will play a key role as we continue to serve a growing list of clients in the United States and beyond," Timothy J. Cunningham, managing partner.

Germundson is a graduate of St. Olaf College. He can be reached at germundson@optisins.com.

Focused exclusively on the insurance-distribution marketplace, Chicago-based OPTIS Partners (www.optisins.com) offers merger & acquisition representation for buyers and sellers, including due-diligence reviews. It provides appraisals of fair market value; financial performance review, including trend analysis and internal controls; and ownership transition and perpetuation planning.

OPTIS Partners was ranked in the top five most active agent-broker M&A advisory firms for 2014 through 2019 by S&P Global Market Intelligence. It's also known for its quarterly and annual reports on trends in insurance agency mergers and acquisitions in the U.S. and Canada.

CONTACT: 

Tim Cunningham 
OPTIS Partners 
cunningham@optisins.com, 312-235-0081

Henry Stimpson 
Stimpson Communications 
508-647-0705
Henry@StimpsonCommunications.com

SOURCE: OPTIS Partners

ReleaseID: 569294